Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
“Cell food” reveals how different metabolic programs regulate T cell persistence

“Cell food” reveals how different metabolic programs regulate T cell persistence

Scientific breakthrough by Sjöberg laureate brings new hope to lung cancer patients

Scientific breakthrough by Sjöberg laureate brings new hope to lung cancer patients

Strip-type urine sensor can aid in cancer diagnosis

Strip-type urine sensor can aid in cancer diagnosis

Pancreatic cancer rates are rising rapidly among younger women, study confirms

Pancreatic cancer rates are rising rapidly among younger women, study confirms

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

UC researcher aims to develop better treatments for KRAS-mutated pancreatic cancer

UC researcher aims to develop better treatments for KRAS-mutated pancreatic cancer

Study finds high levels of hydrogen peroxide in pancreatic cancer cells

Study finds high levels of hydrogen peroxide in pancreatic cancer cells

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Research reveals the cellular origin of cancer-associated fibroblasts

Research reveals the cellular origin of cancer-associated fibroblasts

Study reveals how most-resistant pancreatic cancer cells defy treatment

Study reveals how most-resistant pancreatic cancer cells defy treatment

Cancer mortality in the U.S. has declined 33% since the 90s

Cancer mortality in the U.S. has declined 33% since the 90s

New molecular pathway critical to the initiation of pancreatic tumors discovered

New molecular pathway critical to the initiation of pancreatic tumors discovered

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

UC researcher focuses on studying how gene mutations help pancreatic cancer grow

UC researcher focuses on studying how gene mutations help pancreatic cancer grow

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Clinically relevant biomarker strategies in drug development

Clinically relevant biomarker strategies in drug development

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.